Replimune Group, Inc. Business Finance Contracts & Agreements
28 Contracts & Agreements
- Loan Agreements (4 contracts)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (11)
- Underwriting Agreements (5)
- Warrant Agreements (6)
- Form of Pre-Funded Warrant (Filed With SEC on December 4, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on November 27, 2024)
- Underwriting Agreement dated November 25, 2024 (Filed With SEC on November 27, 2024)
- Form of U.K. Inducement Restricted Stock Unit Grant Agreement (Filed With SEC on November 12, 2024)
- Form of U.K. Inducement Stock Option Grant Agreement (Filed With SEC on November 12, 2024)
- Form of Registration Rights Agreement (Filed With SEC on June 13, 2024)
- Securities Purchase Agreement, dated June 12, 2024, by and among Replimune Group, Inc. and each of the investors as party thereto (Filed With SEC on June 13, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 13, 2024)
- Form of Inducement Restricted Stock Unit Grant Agreement (Filed With SEC on May 16, 2024)
- Form of Inducement Stock Option Grant Agreement (Filed With SEC on May 16, 2024)
- Second Amendment to Loan and Security Agreement, dated as of December 22, 2023, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc (Filed With SEC on February 8, 2024)
- Restricted Stock Unit (Filed With SEC on November 7, 2023)
- Stock Option Grant Agreement, effective as of (Filed With SEC on November 7, 2023)
- Restricted Stock Unit Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Filed With SEC on May 18, 2023)
- Stock Option Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant (Filed With SEC on May 18, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on December 12, 2022)
- Underwriting Agreement dated December 8, 2022 (Filed With SEC on December 12, 2022)
- Restricted Stock Unit Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant (Filed With SEC on May 20, 2021)
- Stock Option Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant (Filed With SEC on May 20, 2021)
- Payoff Letter to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated December 15, 2020 (Filed With SEC on February 4, 2021)
- Underwriting Agreement dated October 21, 2020 (Filed With SEC on October 23, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on June 10, 2020)
- Underwriting Agreement dated June 8, 2020 (Filed With SEC on June 10, 2020)
- First Amendment to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated June 1, 2020 (Filed With SEC on June 3, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on November 18, 2019)
- Underwriting Agreement dated November 14, 2019 (Filed With SEC on November 18, 2019)
- Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated August 7, 2019 (Filed With SEC on August 8, 2019)
- Description of Capital Stock (Filed With SEC on June 28, 2019)
